WANY
VCYT icon

Wealthspire Advisors (New York)’s Veracyte VCYT Stock Holding History

Wealthspire Advisors (New York)’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22
Closed -$756 – 2822
2025
Q3 		$756 Buy
+22
New +$631 ﹤0.01% 2779

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Wealthspire Advisors (New York)'s VCYT Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 22 shares — an estimated $756 sold.

Wealthspire Advisors (New York) first reported a position in VCYT in Q3 2025 and held it in 1 quarter. The position peaked at $756 in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 22 Veracyte shares in Q4 2025, an estimated $756.
  • Wealthspire Advisors (New York) first reported a position in Veracyte in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Veracyte position peaked at $756 in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.